Update: Tarsus Pharmaceuticals Shares Rise After Closing Alkeus Pharmaceuticals Acquisition

03:30 PM EDT, 09/04/2026 (MT Newswires) -- (Updates with the latest stock price movement in the headline and first paragraph.) Tarsus Pharmaceuticals (TARS) shares rose 8.3% in Friday afternoon trading after the company said it has completed its acquisition of retinal disease-focused biotechnology company Alkeus Pharmaceuticals. Tarsus said that with the completion of the acquisition, it adds worldwide rights to ALK-001, a differentiated late-stage oral investigational medicine aimed at targeting the underlying biology of Stargardt's disease. Price: 91.31, Change: +8.11, Percent Change: +9.74